» Articles » PMID: 29379964

Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults

Overview
Journal JAMA Intern Med
Specialty General Medicine
Date 2018 Jan 31
PMID 29379964
Citations 170
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Understanding how diabetes and hypertension prevalence varies within a country as large as India is essential for targeting of prevention, screening, and treatment services. However, to our knowledge there has been no prior nationally representative study of these conditions to guide the design of effective policies.

Objective: To determine the prevalence of diabetes and hypertension in India, and its variation by state, rural vs urban location, and individual-level sociodemographic characteristics.

Design, Setting, And Participants: This was a cross-sectional, nationally representative, population-based study carried out between 2012 and 2014. A total of 1 320 555 adults 18 years or older with plasma glucose (PG) and blood pressure (BP) measurements were included in the analysis.

Exposures: State, rural vs urban location, age, sex, household wealth quintile, education, and marital status.

Main Outcomes And Measures: Diabetes (PG level ≥126 mg/dL if the participant had fasted or ≥200 mg/dL if the participant had not fasted) and hypertension (systolic BP≥140 mm Hg or diastolic BP≥90 mm Hg).

Results: Of the 1 320 555 adults, 701 408 (53.1%) were women. The crude prevalence of diabetes and hypertension was 7.5% (95% CI, 7.3%-7.7%) and 25.3% (95% CI, 25.0%-25.6%), respectively. Notably, hypertension was common even among younger age groups (eg, 18-25 years: 12.1%; 95% CI, 11.8%-12.5%). Being in the richest household wealth quintile compared with being in the poorest quintile was associated with only a modestly higher probability of diabetes (rural: 2.81 percentage points; 95% CI, 2.53-3.08 and urban: 3.47 percentage points; 95% CI, 3.03-3.91) and hypertension (rural: 4.15 percentage points; 95% CI, 3.68-4.61 and urban: 3.01 percentage points; 95% CI, 2.38-3.65). The differences in the probability of both conditions by educational category were generally small (≤2 percentage points). Among states, the crude prevalence of diabetes and hypertension varied from 3.2% (95% CI, 2.7%-3.7%) to 19.9% (95% CI, 17.6%-22.3%), and 18.0% (95% CI, 16.6%-19.5%) to 41.6% (95% CI, 37.8%-45.5%), respectively.

Conclusions And Relevance: Diabetes and hypertension prevalence is high in middle and old age across all geographical areas and sociodemographic groups in India, and hypertension prevalence among young adults is higher than previously thought. Evidence on the variations in prevalence by state, age group, and rural vs urban location is critical to effectively target diabetes and hypertension prevention, screening, and treatment programs to those most in need.

Citing Articles

Care cascades of diabetes and hypertension among late adolescents in India.

Malik B, Goyal A, Maiti S, Mohanty S J Glob Health. 2025; 15:04101.

PMID: 40048318 PMC: 11884645. DOI: 10.7189/jogh.15.04101.


Assessing type-2 diabetes risk based on the Indian diabetes risk score among adults aged 45 and above in India.

Maniyara K, Kodali P Sci Rep. 2025; 15(1):4495.

PMID: 39915651 PMC: 11802721. DOI: 10.1038/s41598-025-88460-z.


Managing high disease burden: a study of medication rationality in diabetes and hypertension in Andhra Pradesh.

Dasari N, Ahmed N, Panda S, Kumari A, Lakshmi T, Vemana H J Diabetes Metab Disord. 2024; 23(2):2123-2129.

PMID: 39610551 PMC: 11599496. DOI: 10.1007/s40200-024-01475-7.


Walking a tightrope: perspectives of non-degree allopathic providers (NDAPs) on providing diabetes and hypertension care in urban informal settlements of Mumbai Metropolitan Region.

Bahuguna M, Spencer J, Ramani S, Pathak S, Shende S, Pantvaidya S BMC Health Serv Res. 2024; 24(1):1452.

PMID: 39578800 PMC: 11583575. DOI: 10.1186/s12913-024-11919-8.


Pharmacovigilance monitoring and treatment adherence in patients on antihypertensive drugs at a tertiary care centre.

Agrawal P, Patrick S, Thomas M, Gupta D, Singh Matreja P, Singh P Drugs Context. 2024; 13.

PMID: 39469027 PMC: 11514578. DOI: 10.7573/dic.2024-5-2.


References
1.
Sacks D, Arnold M, Bakris G, Bruns D, Horvath A, Kirkman M . Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011; 57(6):e1-e47. DOI: 10.1373/clinchem.2010.161596. View

2.
Anjana R, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R . Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia. 2011; 54(12):3022-7. DOI: 10.1007/s00125-011-2291-5. View

3.
. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013; 37 Suppl 1:S81-90. DOI: 10.2337/dc14-S081. View

4.
. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2016; 389(10064):37-55. PMC: 5220163. DOI: 10.1016/S0140-6736(16)31919-5. View

5.
. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387(10027):1513-1530. PMC: 5081106. DOI: 10.1016/S0140-6736(16)00618-8. View